Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 695

1.

Loss of RUNX3 Immunoreactivity in Non-Neoplastic Rectal Mucosa May Predict the Occurrence of Ulcerative Colitis-Associated Colorectal Cancer.

Shinagawa T, Hata K, Morikawa T, Matsunaga K, Emoto S, Murono K, Kaneko M, Sasaki K, Nishikawa T, Tanaka T, Kawai K, Nozawa H, Fukayama M, Ishihara S.

Digestion. 2019 Feb 14:1-9. doi: 10.1159/000497272. [Epub ahead of print]

PMID:
30763934
2.

Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens.

Kohsaka S, Tatsuno K, Ueno T, Nagano M, Shinozaki-Ushiku A, Ushiku T, Takai D, Ikegami M, Kobayashi H, Kage H, Ando M, Hata K, Ueda H, Yamamoto S, Kojima S, Oseto K, Akaike K, Suehara Y, Hayashi T, Saito T, Takahashi F, Takahashi K, Takamochi K, Suzuki K, Nagayama S, Oda Y, Mimori K, Ishihara S, Yatomi Y, Nagase T, Nakajima J, Tanaka S, Fukayama M, Oda K, Nangaku M, Miyazono K, Miyagawa K, Aburatani H, Mano H.

Cancer Sci. 2019 Feb 9. doi: 10.1111/cas.13968. [Epub ahead of print]

3.

Interleukin-13 receptor α2 is a novel marker and potential therapeutic target for human melanoma.

Okamoto H, Yoshimatsu Y, Tomizawa T, Kunita A, Takayama R, Morikawa T, Komura D, Takahashi K, Oshima T, Sato M, Komai M, Podyma-Inoue KA, Uchida H, Hamada H, Fujiu K, Ishikawa S, Fukayama M, Fukuhara T, Watabe T.

Sci Rep. 2019 Feb 4;9(1):1281. doi: 10.1038/s41598-019-39018-3.

4.

Viral loads correlate with upregulation of PD-L1 and worse patient prognosis in Epstein-Barr Virus-associated gastric carcinoma.

Nakayama A, Abe H, Kunita A, Saito R, Kanda T, Yamashita H, Seto Y, Ishikawa S, Fukayama M.

PLoS One. 2019 Jan 29;14(1):e0211358. doi: 10.1371/journal.pone.0211358. eCollection 2019.

5.

Combined hepatocellular-cholangiocarcinoma with angiosarcomatoid change: A case report with immunohistochemical study.

Hakozaki M, Ito S, Fujii T, Kiya Y, Udagawa H, Fukayama M, Fukusato T.

Pathol Int. 2019 Feb;69(2):110-116. doi: 10.1111/pin.12755. Epub 2019 Jan 23.

PMID:
30672653
6.

Gastrointestinal: Reappraisal of the usefulness of percutaneous transhepatic cholangioscopy for indeterminate distal biliary strictures.

Mizuno S, Nakai Y, Tanaka M, Ushiku T, Arita J, Hasegawa K, Fukayama M, Koike K.

J Gastroenterol Hepatol. 2019 Jan 22. doi: 10.1111/jgh.14588. [Epub ahead of print] No abstract available.

PMID:
30669178
7.

Estrogen dermatitis: Case report and examination of estrogen receptor-β in the skin.

Fukayama M, Asano Y, Shinozaki-Ushiku A, Sato S.

J Dermatol. 2019 Jan 10. doi: 10.1111/1346-8138.14750. [Epub ahead of print]

PMID:
30628111
8.

Ectopic expression of Klotho in fibroblast growth factor 23 (FGF23)-producing tumors that cause tumor-induced rickets/osteomalacia (TIO).

Kinoshita Y, Takashi Y, Ito N, Ikegawa S, Mano H, Ushiku T, Fukayama M, Nangaku M, Fukumoto S.

Bone Rep. 2018 Dec 31;10:100192. doi: 10.1016/j.bonr.2018.100192. eCollection 2019 Jun.

9.

Initial and crucial genetic events in intestinal-type gastric intramucosal neoplasia.

Rokutan H, Abe H, Nakamura H, Ushiku T, Arakawa E, Hosoda F, Yachida S, Tsuji Y, Fujishiro M, Koike K, Totoki Y, Fukayama M, Shibata T.

J Pathol. 2018 Nov 26. doi: 10.1002/path.5208. [Epub ahead of print]

PMID:
30474112
10.

BHLHA15-positive Secretory Precursor Cells Can Give Rise to Tumors in Intestine and Colon in Mice.

Hayakawa Y, Tsuboi M, Asfaha S, Kinoshita H, Niikura R, Konishi M, Hata M, Oya Y, Kim W, Middelhoff M, Hikiba Y, Higashijima N, Ihara S, Ushiku T, Fukayama M, Tailor Y, Hirata Y, Guha C, Yan KS, Koike K, Wang TC.

Gastroenterology. 2018 Nov 15. pii: S0016-5085(18)35272-7. doi: 10.1053/j.gastro.2018.11.024. [Epub ahead of print]

PMID:
30448068
11.

EVI1 expression is associated with aggressive behavior in intrahepatic cholangiocarcinoma.

Tanaka M, Shibahara J, Ishikawa S, Ushiku T, Morikawa T, Shinozaki-Ushiku A, Hayashi A, Misumi K, Tanaka A, Katoh H, Sakuma K, Kokudo T, Inagaki Y, Arita J, Sakamoto Y, Hasegawa K, Fukayama M.

Virchows Arch. 2019 Jan;474(1):39-46. doi: 10.1007/s00428-018-2476-0. Epub 2018 Oct 23.

PMID:
30349952
12.

Pine-cone and villi patterns are endoscopic signs suggestive of ulcerative colitis-associated colorectal cancer and dysplasia.

Shinagawa T, Hata K, Morikawa T, Takiyama H, Emoto S, Murono K, Kaneko M, Sasaki K, Nishikawa T, Tanaka T, Kawai K, Fukayama M, Nozawa H.

Gastrointest Endosc. 2019 Mar;89(3):565-575.e3. doi: 10.1016/j.gie.2018.09.037. Epub 2018 Oct 13.

PMID:
30326231
13.

Japanese familial anetoderma: A report of two cases and review of the published work.

Fukayama M, Miyagaki T, Akamata K, Suzuki S, Tanaka M, Sato S.

J Dermatol. 2018 Dec;45(12):1459-1462. doi: 10.1111/1346-8138.14672. Epub 2018 Oct 15.

PMID:
30320485
14.

H3K27me3 deficiency defines a subset of dedifferentiated chondrosarcomas with characteristic clinicopathological features.

Makise N, Sekimizu M, Konishi E, Motoi T, Kubo T, Ikoma H, Watanabe SI, Okuma T, Hiraoka N, Fukayama M, Kawai A, Ichikawa H, Yoshida A.

Mod Pathol. 2018 Oct 5. doi: 10.1038/s41379-018-0140-5. [Epub ahead of print]

PMID:
30291346
15.

Fusion Kinases Identified by Genomic Analyses of Sporadic Microsatellite Instability-High Colorectal Cancers.

Sato K, Kawazu M, Yamamoto Y, Ueno T, Kojima S, Nagae G, Abe H, Soda M, Oga T, Kohsaka S, Sai E, Yamashita Y, Iinuma H, Fukayama M, Aburatani H, Watanabe T, Mano H.

Clin Cancer Res. 2019 Jan 1;25(1):378-389. doi: 10.1158/1078-0432.CCR-18-1574. Epub 2018 Oct 2.

PMID:
30279230
16.

Adenocarcinoma of the esophagogastric junction and its background mucosal pathology: A comparative analysis according to Siewert classification in a Japanese cohort.

Urabe M, Ushiku T, Shinozaki-Ushiku A, Iwasaki A, Yamazawa S, Yamashita H, Seto Y, Fukayama M.

Cancer Med. 2018 Oct;7(10):5145-5154. doi: 10.1002/cam4.1763. Epub 2018 Sep 21.

17.

High CCR4 expression in the tumor microenvironment is a poor prognostic indicator in lung adenocarcinoma.

Karasaki T, Qiang G, Anraku M, Sun Y, Shinozaki-Ushiku A, Sato E, Kashiwabara K, Nagayama K, Nitadori JI, Sato M, Murakawa T, Kakimi K, Fukayama M, Nakajima J.

J Thorac Dis. 2018 Aug;10(8):4741-4750. doi: 10.21037/jtd.2018.07.45.

18.

Correlations between the Recurrence Patterns and Sizes of Lateral Pelvic Lymph Nodes before and after Chemoradiotherapy in Patients with Lower Rectal Cancer.

Shiratori H, Kawai K, Hata K, Tanaka T, Nishikawa T, Sasaki K, Kaneko M, Murono K, Emoto S, Morikawa T, Fukayama M, Nozawa H.

Oncology. 2019;96(1):33-43. doi: 10.1159/000492493. Epub 2018 Sep 13.

PMID:
30212816
19.

Identification of liver fibrosis using the hepatic vein waveform in patients with Fontan circulation.

Nakatsuka T, Soroida Y, Nakagawa H, Shindo T, Sato M, Soma K, Nakagomi R, Kobayashi T, Endo M, Hikita H, Sato M, Gotoh H, Iwai T, Yasui M, Shinozaki-Ushiku A, Shiraga K, Asakai H, Hirata Y, Fukayama M, Ikeda H, Yatomi Y, Tateishi R, Inuzuka R, Koike K.

Hepatol Res. 2018 Sep 4. doi: 10.1111/hepr.13248. [Epub ahead of print]

PMID:
30182424
20.

Three types of metaplasia model through Kras activation, Pten deletion, or Cdh1 deletion in the gastric epithelium.

Kinoshita H, Hayakawa Y, Konishi M, Hata M, Tsuboi M, Hayata Y, Hikiba Y, Ihara S, Nakagawa H, Ikenoue T, Ushiku T, Fukayama M, Hirata Y, Koike K.

J Pathol. 2019 Jan;247(1):35-47. doi: 10.1002/path.5163. Epub 2018 Nov 27.

PMID:
30168144
21.

Development and internal validation of a risk scoring system for gastrointestinal events requiring surgery in gastrointestinal lymphoma patients.

Aoki T, Yamada A, Takahashi M, Niikura R, Toyama K, Ushiku T, Kurokawa M, Momose T, Fukayama M, Koike K.

J Gastroenterol Hepatol. 2018 Aug 27. doi: 10.1111/jgh.14452. [Epub ahead of print]

PMID:
30151937
22.

Chemical Landscape for Tissue Clearing Based on Hydrophilic Reagents.

Tainaka K, Murakami TC, Susaki EA, Shimizu C, Saito R, Takahashi K, Hayashi-Takagi A, Sekiya H, Arima Y, Nojima S, Ikemura M, Ushiku T, Shimizu Y, Murakami M, Tanaka KF, Iino M, Kasai H, Sasaoka T, Kobayashi K, Miyazono K, Morii E, Isa T, Fukayama M, Kakita A, Ueda HR.

Cell Rep. 2018 Aug 21;24(8):2196-2210.e9. doi: 10.1016/j.celrep.2018.07.056.

23.

The prognostic value of PD-L1 expression in upper tract urothelial carcinoma varies according to platelet count.

Miyama Y, Morikawa T, Miyakawa J, Koyama Y, Kawai T, Kume H, Fukayama M.

Cancer Med. 2018 Sep;7(9):4330-4338. doi: 10.1002/cam4.1686. Epub 2018 Jul 31.

24.

Frequent CLDN18-ARHGAP fusion in highly metastatic diffuse-type gastric cancer with relatively early onset.

Tanaka A, Ishikawa S, Ushiku T, Yamazawa S, Katoh H, Hayashi A, Kunita A, Fukayama M.

Oncotarget. 2018 Jun 29;9(50):29336-29350. doi: 10.18632/oncotarget.25464. eCollection 2018 Jun 29.

25.

Prognostic factors of Erdheim-Chester disease: a nationwide survey in Japan.

Toya T, Ogura M, Toyama K, Yoshimi A, Shinozaki-Ushiku A, Honda A, Honda K, Hosoya N, Murakami Y, Kawashima H, Nannya Y, Arai S, Nakamura F, Shinoda Y, Nangaku M, Miyagawa K, Fukayama M, Moriya-Saito A, Katayama I, Ogura T, Kurokawa M.

Haematologica. 2018 Nov;103(11):1815-1824. doi: 10.3324/haematol.2018.190728. Epub 2018 Jul 5.

26.

Host MICA Polymorphism as a Potential Predictive Marker in Response to Chemotherapy for Colorectal Liver Metastases.

Nishioka Y, Shindoh J, Inagaki Y, Gonoi W, Mitsui J, Abe H, Yoshioka R, Yoshida S, Fukayama M, Tsuji S, Hashimoto M, Hasegawa K, Kokudo N.

Dig Dis. 2018;36(6):437-445. doi: 10.1159/000490411. Epub 2018 Jul 3.

PMID:
29969766
27.

MED12 is frequently mutated in ovarian and other adnexal leiomyomas.

Li Z, Maeda D, Kudo-Asabe Y, Tamura D, Nanjo H, Hayashi A, Ikemura M, Fukayama M, Goto A.

Hum Pathol. 2018 Nov;81:89-95. doi: 10.1016/j.humpath.2018.06.013. Epub 2018 Jun 23.

PMID:
29944972
28.

Gastritis-Infection-Cancer Sequence of Epstein-Barr Virus-Associated Gastric Cancer.

Fukayama M, Kunita A, Kaneda A.

Adv Exp Med Biol. 2018;1045:437-457. doi: 10.1007/978-981-10-7230-7_20. Review.

PMID:
29896679
29.

MicroRNA-21 in cancer-associated fibroblasts supports lung adenocarcinoma progression.

Kunita A, Morita S, Irisa TU, Goto A, Niki T, Takai D, Nakajima J, Fukayama M.

Sci Rep. 2018 Jun 11;8(1):8838. doi: 10.1038/s41598-018-27128-3.

30.

A phase II trial of gemcitabine, S-1 and LV combination (GSL) neoadjuvant chemotherapy for patients with borderline resectable and locally advanced pancreatic cancer.

Saito K, Isayama H, Sakamoto Y, Nakai Y, Ishigaki K, Tanaka M, Watadani T, Arita J, Takahara N, Mizuno S, Kogure H, Ijichi H, Tateishi K, Tada M, Hasegawa K, Fukayama M, Kokudo N, Koike K.

Med Oncol. 2018 May 30;35(7):100. doi: 10.1007/s12032-018-1158-8.

PMID:
29846849
31.

Extranodal NK/T-cell lymphoma of the nasal cavity developed in a patient with intestinal Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder.

Furuya G, Abe H, Shinozaki-Ushiku A, Yamashita A, Ihara S, Hirata Y, Chiba A, Fujioka Y, Kurokawa M, Koike K, Fukayama M.

Pathol Res Pract. 2018 Jul;214(7):1051-1055. doi: 10.1016/j.prp.2018.05.022. Epub 2018 May 22.

PMID:
29843925
32.

Hepatic IRS1 and ß-catenin expression is associated with histological progression and overt diabetes emergence in NAFLD patients.

Enooku K, Kondo M, Fujiwara N, Sasako T, Shibahara J, Kado A, Okushin K, Fujinaga H, Tsutsumi T, Nakagomi R, Minami T, Sato M, Nakagawa H, Kondo Y, Asaoka Y, Tateishi R, Ueki K, Ikeda H, Yoshida H, Moriya K, Yotsuyanagi H, Kadowaki T, Fukayama M, Koike K.

J Gastroenterol. 2018 Dec;53(12):1261-1275. doi: 10.1007/s00535-018-1472-0. Epub 2018 May 10.

33.

Pancreatic Lipomatous Hamartoma: A Hitherto Unrecognized Variant.

Tanaka M, Ushiku T, Ikemura M, Takazawa Y, Igari T, Shimizu M, Yamaguchi H, Fukushima N, Sakuma K, Arita J, Sakamoto Y, Hasegawa K, Watadani T, Nakai Y, Koike K, Fukayama M.

Am J Surg Pathol. 2018 Jul;42(7):891-897. doi: 10.1097/PAS.0000000000001075.

PMID:
29738363
34.

Glomeruloid hemangioma associated with TAFRO syndrome.

Shinozaki-Ushiku A, Higashihara T, Ikemura M, Sato J, Nangaku M, Ushiku T, Fukayama M.

Hum Pathol. 2018 Dec;82:172-176. doi: 10.1016/j.humpath.2018.04.011. Epub 2018 Apr 25.

PMID:
29702119
35.

Blood Vessel Invasion Is a Strong Predictor of Postoperative Recurrence in Endometrial Cancer.

Sato M, Taguchi A, Fukui Y, Kawata A, Taguchi S, Kashiyama T, Eguchi S, Inoue T, Tomio K, Tanikawa M, Sone K, Mori M, Nagasaka K, Adachi K, Ikemura M, Domoto Y, Arimoto T, Oda K, Fukayama M, Osuga Y, Fujii T.

Int J Gynecol Cancer. 2018 Jun;28(5):875-881. doi: 10.1097/IGC.0000000000001262.

PMID:
29664845
36.

Histological transformation of MALT lymphoma to plasma cell leukemia after rituximab-containing therapy.

Suzuki Y, Honda A, Nakazaki K, Mizuno H, Ikemura M, Shinozaki-Ushiku A, Nakamura F, Fukayama M, Kurokawa M.

Ann Hematol. 2018 Jul;97(7):1297-1298. doi: 10.1007/s00277-018-3300-2. Epub 2018 Mar 26. No abstract available.

PMID:
29582109
37.

Sessile serrated adenoma detection rate is correlated with adenoma detection rate.

Ohki D, Tsuji Y, Shinozaki T, Sakaguchi Y, Minatsuki C, Kinoshita H, Niimi K, Ono S, Hayakawa Y, Yoshida S, Yamada A, Kodashima S, Yamamichi N, Hirata Y, Ushiku T, Fujishiro M, Fukayama M, Koike K.

World J Gastrointest Oncol. 2018 Mar 15;10(3):82-90. doi: 10.4251/wjgo.v10.i3.82.

38.

CD47 expression in Epstein-Barr virus-associated gastric carcinoma: coexistence with tumor immunity lowering the ratio of CD8+/Foxp3+ T cells.

Abe H, Saito R, Ichimura T, Iwasaki A, Yamazawa S, Shinozaki-Ushiku A, Morikawa T, Ushiku T, Yamashita H, Seto Y, Fukayama M.

Virchows Arch. 2018 Apr;472(4):643-651. doi: 10.1007/s00428-018-2332-2. Epub 2018 Mar 13.

PMID:
29536167
39.

Eculizumab treatment for ischemic enteritis accompanied with paroxysmal nocturnal hemoglobinuria: a case report and literature review.

Yasunaga M, Taoka K, Nakagawa H, Yamada A, Abe H, Jona M, Nishikawa M, Nakazaki K, Yatomi Y, Fukayama M, Koike K, Kurokawa M.

Ann Hematol. 2018 Aug;97(8):1513-1515. doi: 10.1007/s00277-018-3286-9. Epub 2018 Mar 13. Review. No abstract available.

PMID:
29532162
40.

Extraskeletal osteosarcoma: MDM2 and H3K27me3 analysis of 19 cases suggest disease heterogeneity.

Makise N, Sekimizu M, Kubo T, Wakai S, Watanabe SI, Kato T, Kinoshita T, Hiraoka N, Fukayama M, Kawai A, Ichikawa H, Yoshida A.

Histopathology. 2018 Jul;73(1):147-156. doi: 10.1111/his.13506. Epub 2018 Apr 19.

PMID:
29489027
41.

Synergistic Cytotoxic Effect on Gastric Cancer Cells of an Immunotoxin Cocktail in Which Antibodies Recognize Different Epitopes on CDH17.

Kusano-Arai O, Iwanari H, Kudo S, Kikuchi C, Yui A, Akiba H, Matsusaka K, Kaneda A, Fukayama M, Tsumoto K, Hamakubo T.

Monoclon Antib Immunodiagn Immunother. 2018 Feb;37(1):1-11. doi: 10.1089/mab.2017.0043.

PMID:
29474162
42.

A 19-Gauge Histology Needle Versus a 19-Gauge Standard Needle in Endoscopic Ultrasound-Guided Fine-Needle Aspiration for Solid Lesions: A Multicenter Randomized Comparison Study (GREATER Study).

Iwashita T, Nakai Y, Mukai T, Togawa O, Matsubara S, Hatano Y, Hara A, Tanaka M, Shibahara J, Fukayama M, Isayama H, Yasuda I.

Dig Dis Sci. 2018 Apr;63(4):1043-1051. doi: 10.1007/s10620-018-4913-y. Epub 2018 Feb 21.

PMID:
29464585
43.

Inflammatory Cytokines Induce Podoplanin Expression at the Tumor Invasive Front.

Kunita A, Baeriswyl V, Meda C, Cabuy E, Takeshita K, Giraudo E, Wicki A, Fukayama M, Christofori G.

Am J Pathol. 2018 May;188(5):1276-1288. doi: 10.1016/j.ajpath.2018.01.016. Epub 2018 Feb 17.

PMID:
29458011
44.

Distinct Chemopreventive Effects of Aspirin in Diffuse and Intestinal-Type Gastric Cancer.

Niikura R, Hayakawa Y, Hirata Y, Konishi M, Suzuki N, Ihara S, Yamada A, Ushiku T, Fujishiro M, Fukayama M, Koike K.

Cancer Prev Res (Phila). 2018 May;11(5):279-286. doi: 10.1158/1940-6207.CAPR-17-0276. Epub 2018 Feb 16.

PMID:
29453233
45.

CPT2 downregulation adapts HCC to lipid-rich environment and promotes carcinogenesis via acylcarnitine accumulation in obesity.

Fujiwara N, Nakagawa H, Enooku K, Kudo Y, Hayata Y, Nakatsuka T, Tanaka Y, Tateishi R, Hikiba Y, Misumi K, Tanaka M, Hayashi A, Shibahara J, Fukayama M, Arita J, Hasegawa K, Hirschfield H, Hoshida Y, Hirata Y, Otsuka M, Tateishi K, Koike K.

Gut. 2018 Aug;67(8):1493-1504. doi: 10.1136/gutjnl-2017-315193. Epub 2018 Feb 6.

PMID:
29437870
46.

The Japanese Society of Pathology Guidelines on the handling of pathological tissue samples for genomic research: Standard operating procedures based on empirical analyses.

Kanai Y, Nishihara H, Miyagi Y, Tsuruyama T, Taguchi K, Katoh H, Takeuchi T, Gotoh M, Kuramoto J, Arai E, Ojima H, Shibuya A, Yoshida T, Akahane T, Kasajima R, Morita KI, Inazawa J, Sasaki T, Fukayama M, Oda Y.

Pathol Int. 2018 Feb;68(2):63-90. doi: 10.1111/pin.12631.

PMID:
29431262
47.

Protrusion on the Depressed Surface of Non-polypoid T1 Colorectal Cancer Is Associated with Venous Invasion.

Shinagawa T, Hata K, Morikawa T, Takiyama H, Otani K, Nishikawa T, Tanaka T, Kiyomatsu T, Kawai K, Nozawa H, Ishihara S, Nakamura H, Fukayama M, Watanabe T.

Anticancer Res. 2018 Feb;38(2):993-1002.

PMID:
29374732
48.

Value of FDG-PET/CT Volumetry After Chemoradiotherapy in Rectal Cancer.

Okuno T, Kawai K, Koyama K, Takahashi M, Ishihara S, Momose T, Morikawa T, Fukayama M, Watanabe T.

Dis Colon Rectum. 2018 Mar;61(3):320-327. doi: 10.1097/DCR.0000000000000959.

PMID:
29360680
49.

Transparency-enhancing technology allows three-dimensional assessment of gastrointestinal mucosa: A porcine model.

Mizutani H, Ono S, Ushiku T, Kudo Y, Ikemura M, Kageyama N, Yamamichi N, Fujishiro M, Someya T, Fukayama M, Koike K, Onodera H.

Pathol Int. 2018 Feb;68(2):102-108. doi: 10.1111/pin.12627. Epub 2018 Jan 17.

PMID:
29341375
50.

Clarifying the Distinction Between Malignant Peripheral Nerve Sheath Tumor and Dedifferentiated Liposarcoma: A Critical Reappraisal of the Diagnostic Utility of MDM2 and H3K27me3 Status.

Makise N, Sekimizu M, Kubo T, Wakai S, Hiraoka N, Komiyama M, Fukayama M, Kawai A, Ichikawa H, Yoshida A.

Am J Surg Pathol. 2018 May;42(5):656-664. doi: 10.1097/PAS.0000000000001014.

PMID:
29309298

Supplemental Content

Loading ...
Support Center